Article
Open Access Article

Oncology Nurses' Awareness of Cognitive Impairment Secondary to Chemotherapy

Jamie S. Myers

Cynthia Teel

cognitive impairment, chemotherapy, quality of life
CJON 2008, 12(5), 725-729. DOI: 10.1188/08.CJON.725-729

The purpose of this cross-sectional, descriptive pilot study was to collect frequency data for oncology nurses' awareness of cognitive impairment (CI) secondary to chemotherapy, practice patterns related to assessment and education of patients and families about CI, and access to related educational materials. A convenience sample of 34 RNs was used in conjunction with a local Oncology Nursing Society chapter meeting. An 18-item survey was developed and piloted to collect data and demographic information from participants. Participants (100%) acknowledged awareness of chemotherapy-related CI. Most (94%) had attended educational programming on the topic and agreed that their patients had mentioned CI. Only 38% of participants assessed patients for CI and 44% educated patients and families on the topic. All nurses agreed that CI had some impact on patients' ability to perform activities of daily living and that CI caused at least some degree of distress. Most participants (71%) did not have access to related patient and family educational tools. The study provided support for the development of educational programs related to appropriate patient assessment and the development and distribution of related patient and family educational tools.

Jump to a section

    References

    Ahles, T. A., & Saykin, A. J. (2001). Cognitive effects of standarddose chemotherapy in patients with cancer. Cancer Investigation, 19(8), 812-820.
    Ahles, T. A., & Saykin, A. J. (2002). Breast cancer chemotherapyrelated cognitive dysfunction. Clinical Breast Cancer Supplement, 3(Suppl. 3), S84-S90.
    Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192-201.
    Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standarddose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
    Aubin, M., Vezina, L., Parent, R., Fillion, L., Allard, P., Bergeron, R., et al. (2006). Impact of an educational program on pain management in patients with cancer living at home. Oncology Nursing Forum, 33(6), 1183-1188.
    Belleau, F. P., Hagan, L., & Masse, B. (2001). Effects of an educational intervention on the anxiety of women awaiting mastectomies. Canadadian Oncology Nursing Journal, 11(4), 172-180.
    Benor, D. E., Delbar, V., & Krulik, T. (1998). Measuring impact of nursing interventions on cancer patients' ability to control symptoms. Cancer Nursing, 21(5), 320-334.
    Castellon, S. A., Ganz, P. A., Bower, J. E., Peterson, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26(7), 955-969.
    Jackson, H. A. (2002). The development of an admission tool for the assessment of the palliative care symptom: Pain. Retrieved January 24, 2008, from http://www.ons.org/outcomes/measures/survey.shtml
    Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncology Nursing Forum, 32(6), 1151-1163.
    Johnson, M., & Henke Yarbro, C. (2000). Principles of oncology nursing. In J. F. Holland & E. Frei (Eds.), Cancer medicine (5th ed., pp. 959-970). Hamilton: B. C. Decker, Inc.
    Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., Muller, M. J., et al. (2006). Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: An electrophysiologic study. Clinical Breast Cancer, 7(1), 67-78.
    Mancuso, A., Migliorino, M., De Santis, S., Saponiero, A., & De Marinis, F. (2006). Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of Oncology, 17(1), 146-150.
    Massa, E., Madeddu, C., Lusso, M. R., Gramignano, G., & Mantovani, G. (2006). Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Critical Reviews in Oncology/Hematology, 57(2), 175-182.
    Oncology Nursing Society. (2006). Oncology services in the ambulatory setting [Position statement]. Retrieved August 8, 2007, from http://www.ons.org/publications/positions/RevAmbulatoryPractice.shtml
    O'Shaughnessy, J. (2003). Chemotherapy-related cognitive dysfunction in breast cancer. Seminars in Oncology Nursing, 19(4, Suppl. 2), 17-24.
    Polovich, M., Olsen, M., & Whitford, J. (Eds.). (in press). Chemotherapy and biotherapy guidelines and recommendations for practice (3rd ed.). Pittsburgh, PA: Oncology Nursing Society.
    Schagen, S. B., Muller, M. J., Boogerd, W., & van Dam, F. S. (2002). Cognitive dysfunction and chemotherapy: Neuropsychological findings in perspective. Clinical Breast Cancer, 3(Suppl. 3), S100-S108.
    Shapiro, P. J., Jacobs, L. A., Palmer, S. C., Coyne, J. C., Meadows, A. T., & Vaughn, D. J. (2005). Neurocognitive function (NCF) in long-term survivors of testicular cancer (TC) [Abstract 8034]. Journal of Clinical Oncology, 23(16, Suppl.), 737s.
    Smith, J., Forster, A., & Young, J. (2004). A randomized trial to evaluate an education programme for patients and carers after stroke. Clinical Rehabilitation, 18(7), 726-736.
    Troy, L., McFarland, K., Littman-Power, S., Kelly, B. J., Walpole, E. T., Wyld, D., et al. (2000). Cisplatin-based therapy: A neurological and neuropsychological review. Psycho-Oncology, 9(1), 29-39.
    Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer, 100(11), 2292-2299.